1-20 of 29
Kelly N. Godby
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Optimal Induction and Consolidation Strategy for Patients with Complex Karyotype and TP53 -Mutated Acute Myeloid Leukemia

Omer H Jamy, Kendall Diebold, Kimo Bachiashvili, Sravanti Rangaraju, Pankit Vachhani, Kelly N. Godby, Donna Salzman, Ravi Bhatia
Journal: Blood
Blood (2022) 140 (Supplement 1): 8959–8960.
https://doi.org/10.1182/blood-2022-160346
Published: 2022
Journal Articles

Quadruplet Induction, Autologous Transplantation and Minimal Residual Disease Adapted Consolidation and Treatment Cessation in Older Adults ≥70y with Newly Diagnosed Multiple Myeloma: A Subgroup Analysis of the Master Trial

Smith Giri, Saurabh Chhabra, Eva Medvedova, Bhagirathbhai Dholaria, Timothy Martin Schmidt, Kelly N. Godby, Rebecca Silbermann, Binod Dhakal, Susan Bal, Anita D'Souza, Aric C. Hall, Pamela Hardwick, Jim Omel, Robert Frank Cornell, Natalie Callander, Parameswaran Hari, Luciano J. Costa
Journal: Blood
Blood (2022) 140 (Supplement 1): 4431–4433.
https://doi.org/10.1182/blood-2022-160381
Published: 2022
Journal Articles

Induction Quadruplet Therapy and Minimal/Measurable Residual Disease (MRD)-Informed Treatment Adaptation in Newly Diagnosed Multiple Myeloma (NDMM): Results from an Academic-Community Pathway

Gayathri Ravi, Smith Giri, Susan Bal, Kelly N. Godby, Vishnu V.B. Reddy, Donna Salzman, Omar Alkharabsheh, Scott A. McDaniel, Melissa Sentell, Luciano J. Costa
Journal: Blood
Blood (2022) 140 (Supplement 1): 8048–8049.
https://doi.org/10.1182/blood-2022-170099
Published: 2022
Journal Articles

Safety, Feasibility, and Efficacy of Upfront Daratumumab-Based Therapy in Blacks with Dysproteinemia

Hyndavi Kandala, Smith Giri, Gayathri Ravi, Kelly N. Godby, Deanna Clark, Clare Ubersax, Luciano J. Costa, Susan Bal
Journal: Blood
Blood (2022) 140 (Supplement 1): 13198–13199.
https://doi.org/10.1182/blood-2022-170978
Published: 2022
Journal Articles

Outcomes of MRD-Adapted Treatment Modulation in Patients with Newly Diagnosed Multiple Myeloma Receiving Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone (Dara-KRd) and Autologous Transplantation: Extended Follow up of the Master Trial

Luciano J. Costa, Saurabh Chhabra, Eva Medvedova, Timothy Martin Schmidt, Bhagirathbhai Dholaria, Kelly N. Godby, Rebecca Silbermann, Susan Bal, Anita D'Souza, Smith Giri, James L. Omel, Parameswaran Hari, Natalie Callander, Binod Dhakal
Journal: Blood
Blood (2022) 140 (Supplement 1): 7275–7277.
https://doi.org/10.1182/blood-2022-156730
Published: 2022
Journal Articles

Analysis of Transplant-Eligible Patients (Pts) Who Received Frontline Daratumumab (DARA)-Based Quadruplet Therapy for the Treatment of Newly Diagnosed Multiple Myeloma (NDMM) with High-Risk Cytogenetic Abnormalities (HRCA) in the Griffin and Master Studies

Natalie Callander, Rebecca Silbermann, Jonathan L. Kaufman, Kelly N. Godby, Jacob P Laubach, Timothy Martin Schmidt, Douglas W Sborov, Eva Medvedova, Brandi Reeves, Binod Dhakal, Cesar Rodriguez, Saurabh Chhabra, Ajai Chari, Susan Bal, Larry D. Anderson, Jr., Bhagirathbhai Dholaria, Nitya Nathwani, Parameswaran Hari, Nina Shah, Naresh Bumma, Sarah A. Holstein, Caitlin Costello, Andrzej Jakubowiak, Tanya M. Wildes, Robert Z. Orlowski, Ken H. Shain, Andrew J. Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S. Lin, Smith Giri, Luciano J. Costa, Paul G. Richardson, Saad Usmani, Peter M. Voorhees
Journal: Blood
Blood (2022) 140 (Supplement 1): 10144–10147.
https://doi.org/10.1182/blood-2022-160451
Published: 2022
Journal Articles

Drug Class Refractoriness, Not Number of Prior Lines of Therapy (LOT), Properly Classify Patients with Relapsed and Refractory Multiple Myeloma (RRMM) Receiving Contemporary Regimens

Luciano J. Costa, Kelly N. Godby, Gayathri Ravi, Smith Giri, Susan Bal
Journal: Blood
Blood (2022) 140 (Supplement 1): 10084–10085.
https://doi.org/10.1182/blood-2022-165882
Published: 2022
Journal Articles

Evaluating Concordance between International Myeloma Working Group (IMWG) and Simplified Frailty Index (SFI) Among Older Adults with Multiple Myeloma (MM)

Andrew Gahagan, Sunil Rangarajan, Clare Ubersax, Abigail Tucker, Christian Harmon, Monica Sai Pasala, Susan Bal, Kelly N. Godby, Gayathri Ravi, Luciano J. Costa, Grant Williams, Smita Bhatia, Smith Giri
Journal: Blood
Blood (2022) 140 (Supplement 1): 10079–10080.
https://doi.org/10.1182/blood-2022-165432
Published: 2022
Journal Articles

Humoral Immune Reconstitution Following Therapy with Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone (Dara-KRd), Autologous Hematopoietic Cell Transplantation (AHCT) and MRD-Response-Adapted Treatment Cessation

Timothy Martin Schmidt, Rebecca Silbermann, Susan Bal, Binod Dhakal, Bhagirathbhai Dholaria, Eden Biltibo, Saurabh Chhabra, Smith Giri, Kelly N. Godby, Sonia Gowda, Eva Medvedova, Natalie Callander, Luciano J. Costa
Journal: Blood
Blood (2022) 140 (Supplement 1): 10077–10078.
https://doi.org/10.1182/blood-2022-164930
Published: 2022
Journal Articles

Prevalence and Impact of Potentially Inappropriate Medication Use on Post-Transplant Outcomes Among Older Adults with Plasma Cell Dyscrasias Receiving an Autologous Stem Cell Transplant

Nicole Watts, Courtney Hebert, Clare Ubersax, Deanna Clark, Gayathri Ravi, Susan Bal, Purnima Singh, Kelly N. Godby, Donna Salzman, Luciano J. Costa, Grant Williams, Smita Bhatia, Smith Giri
Journal: Blood
Blood (2022) 140 (Supplement 1): 5248–5249.
https://doi.org/10.1182/blood-2022-163649
Published: 2022
Journal Articles

Efficacy of Treatments for Patients with Triple-Class Refractory (TCR) Multiple Myeloma (MM): Benchmark for New Agents Utilizing Real-World Data (RWD)

Luciano J. Costa, Robert Frank Cornell, Natalie S. Callander, Saurabh Chhabra, Michaela Liedtke, Ankit Kansagra, Kelly N. Godby, Susan Bal, Smith Giri, Ehsan Malek, Yubin Kang, Ravi Vij, Saad Z. Usmani, Parameswaran Hari, Shaji Kumar
Journal: Blood
Blood (2021) 138 (Supplement 1): 3786.
https://doi.org/10.1182/blood-2021-144387
Published: 2021
Journal Articles

Biologic Basis of the Impact of Autologous Hematopoietic Cell Transplantation in Multiple Myeloma Treated with Quadruplet Therapy

Susan Bal, Saurabh Chhabra, Natalie S. Callander, Eva Medvedova, Bhagirathbhai Dholaria, Rebecca W. Silbermann, Kelly N. Godby, Binod Dhakal, Smith Giri, Anita d'Souza, Timothy M. Schmidt, Aric C. Hall, Pamela Hardwick, Robert F. Cornell, Parameswaran Hari, Luciano J. Costa
Journal: Blood
Blood (2021) 138 (Supplement 1): 483.
https://doi.org/10.1182/blood-2021-145533
Published: 2021
Journal Articles

Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone (Dara-KRd), Autologous Transplantation and MRD Response-Adapted Consolidation and Treatment Cessation. Final Primary Endpoint Analysis of the Master Trial

Luciano J. Costa, Saurabh Chhabra, Natalie S. Callander, Eva Medvedova, Bhagirathbhai Dholaria, Rebecca W. Silbermann, Kelly N. Godby, Binod Dhakal, Susan Bal, Smith Giri, Anita d'Souza, Timothy M. Schmidt, Aric C. Hall, Pamela Hardwick, Robert F. Cornell, Parameswaran Hari
Journal: Blood
Blood (2021) 138 (Supplement 1): 481.
https://doi.org/10.1182/blood-2021-145494
Published: 2021
Journal Articles

Managing Multiple Myeloma in Older Adults Using Real World Evidence and Clinical Integration of a Geriatric Assessment Tool in Clinical Practice

Smith Giri, D'Ambra Dent, Kelly N. Godby, Luciano J. Costa, Susan Bal, Gayathri Ravi, Stacey Ingram, William Dudley, Matthew Dudley, Julie M Scott, Debra M Wujcik
Journal: Blood
Blood (2021) 138 (Supplement 1): 5019.
https://doi.org/10.1182/blood-2021-153753
Published: 2021
Journal Articles

Real-World Applicability of Commercial Chimeric Antigen Receptor T Cell Therapy Among Older Adults with Relapsed and/or Refractory Multiple Myeloma

Smith Giri, Susan Bal, Kelly N. Godby, Gayathri Ravi, Deanna Clark, Clare Ubersax, Abigail Cooley, Priscila White, Sunil Rangarajan, Grant R Williams, Luciano J. Costa
Journal: Blood
Blood (2021) 138 (Supplement 1): 4107.
https://doi.org/10.1182/blood-2021-153796
Published: 2021
Journal Articles

High Dose Fractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone (mHyperCVAD) Is an Active Regimen in Heavily Pretreated Relapsed/Refractory Multiple Myeloma, Enabling Access to Experimental Therapies

Nicole Watts, Smith Giri, Kelly N. Godby, Gayathri Ravi, Luciano J. Costa, Susan Bal
Journal: Blood
Blood (2021) 138 (Supplement 1): 3784.
https://doi.org/10.1182/blood-2021-154071
Published: 2021
Journal Articles

Revisiting the Impact of Immunoglobulin Isotypes in Multiple Myeloma

Susan Bal, MDMBBS, Smith Giri, MBBS, Kelly N. Godby, MD, Luciano J. Costa, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 19.
https://doi.org/10.1182/blood-2020-138903
Published: 2020
Journal Articles

Role of Neutrophil Lymphocyte Ratio [NLR] As a Biomarker of Frailty and Predictor of Survival Among Older Adults with Multiple Myeloma (MM)

Smith Giri, MDMS, Susan Bal, MDMBBS, Kelly N. Godby, MD, Joshua Richman, MD PhD, Adam J Olszewski, MD, Grant R Williams, Luciano J. Costa, MD PhD, Smita Bhatia, MDMPH
Journal: Blood
Blood (2020) 136 (Supplement 1): 6.
https://doi.org/10.1182/blood-2020-143290
Published: 2020
Journal Articles

Multiple Myeloma (MM) in the Very Old: Disease Characteristics, Treatment Patterns and Outcomes in the Real World

Smith Giri, MDMS, Susan Bal, MDMBBS, Kelly N. Godby, MD, Grant R Williams, Luciano J. Costa, MD PhD, Smita Bhatia, MDMPH
Journal: Blood
Blood (2020) 136 (Supplement 1): 21–22.
https://doi.org/10.1182/blood-2020-143223
Published: 2020
Journal Articles

Redefining the Prognostic Significance of t(11;14) Multiple Myeloma

Susan Bal, MDMBBS, Smith Giri, MBBS, Kelly N. Godby, MD, Luciano J. Costa, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 43.
https://doi.org/10.1182/blood-2020-138888
Published: 2020